Global In-Vitro Diagnostics for Cardiology, Neurology Therapeutics Growth, Trends and Forecasts 2017 - 2022

  • ID: 4388010
  • Report
  • Region: Global
  • 192 pages
  • Mordor Intelligence
1 of 4
The In-Vitro diagnostic market is valued as a USD 17 billion market in 2013 and is expected to become a USD 25 billion by 2020, growing at a CAGR of 5.66%

Global In-Vitro Diagnostics for Cardiology and Neurology Therapeutics Market- Market Dynamics

The report details several driving and restraining factors for the market. Some of them are listed below.

Drivers

Widespread healthcare awareness

Increased spending capabilities of people on healthcare

High demand for technologically advanced equipment for the early and precise diagnosis of various diseases

Increase in number of incidences of the diseases

Minimally invasive and point of care techniques for diagnosis

The technological advancements and new developments in the diagnostic industry

Growing and rapidly aging population

Restraints

Stringent regulatory policies by governments

Reimbursement issues

Lack of funds

The market is segmented into different categories on the basis of techniques, products, usability, applications, end user and geographically. The technique segment is divided into categories like molecular diagnostics, point of care diagnostics, immunoassay, and clinical chemistry. The products segmentation included instruments, reagents, and data management. The applications segment includes the fields of oncology, hematology, diabetes, cardiology, etc. The end-users are academics, hospitals, and laboratories.

The market analysis is available for the geographical areas of North America, Europe, APAC and Rest of the World.

Key Deliverables:

Market analysis for the In-Vitro Diagnostics for Cardiology and Neurology Therapeutics market, with region-specific assessments and competition analysis on the global and regional scale.

Market definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their market share.

Identification and analysis of the macro and micro factors that affect the market on both global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.

Insights on the major countries/regions where this industry is blooming and to also identify the regions that are still untapped.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
1. INTRODUCTION
1.1 Report Description
1.2 Research Methodology
1.3 Stakeholders
2. EXECUTIVE SUMMARY
2.1 Key Findings
2.2 Market Overview
3. MARKET OVERVIEW
3.1 Market Definition
3.1.1 Introduction
3.2 Market Segmentation
3.2.1 Technique
3.2.2 Product
3.2.3 Usability
3.2.4 Application
3.2.5 End User
3.2.6 Geography
3.3 Market Drivers
3.3.1 Increase in the number of chronic & infectious diseases
3.3.2 Rapid aging population
3.3.3 Technological Advancements
3.4 Market Restraints
3.4.1 Stringent Regulatory Framework
3.4.2 Lack of Reimbursement
3.4.3 Lack of budget
4. GLOBAL MARKETS: SEGMENTATION BY APPLICATION
4.1 Infectious Diseases
4.2 Diabetes
4.3 Cancer/Oncology
4.4 Cardiology
4.5 Auto Immune Diseases
4.6 Nephrology
4.7 Drug Testing
4.8 HIV/AIDS
4.9 Others
5. GLOBAL MARKETS: SEGMENTATION BY GEOGRAPHY
5.1 North America
5.2 Europe
5.3 Rest of the World
5.4 APAC
6. COMPETITVE LANDSCAPE
6.1 Introduction
6.2 Mergers & Acquisitions
6.3 Expansions
6.4 New Product Launch
6.5 Collaborations
7. COMPANY PROFILES
7.1 Alere Inc
7.2 Biomerieux
7.3 Danaher Corporation
7.4 Roche Diagnostics
7.5 Becton Dickinson & Company
7.6 BioRad Laboratories
7.7 Abbott Laboratories
7.8 Bayer AG
7.9 Arkray Inc
7.10 Sysmex
7.11 Johnson & Johnsons
7.12 Siemens
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll